Bemsivir Injection 5 mg/ml contains Remdesivir, a broad-spectrum antiviral agent used in the treatment of serious viral infections caused by RNA viruses. It is most widely indicated for the management of hospitalized patients with severe viral respiratory infections, where antiviral therapy is clinically justified. Bemsivir Injection is administered intravenously under strict medical supervision in hospital settings.

Remdesivir works by inhibiting viral replication, thereby reducing viral load and helping to improve clinical outcomes in patients with severe viral illness. Its use is guided by clinical protocols and physician judgment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Remdesivir 5 mg/ml

Therapeutic Class

Antiviral agent (RNA polymerase inhibitor)

Indications

Bemsivir Injection 5 mg/ml is indicated for:

• Treatment of severe viral infections caused by susceptible RNA viruses

• Use in hospitalized patients requiring antiviral therapy

• Management of viral pneumonia and related complications under specialist care

Pharmacology

Remdesivir is a nucleotide analog prodrug that is metabolized intracellularly to its active form, remdesivir triphosphate. This active metabolite inhibits viral RNA-dependent RNA polymerase, an enzyme essential for viral genome replication.

By incorporating into the viral RNA chain, Remdesivir causes premature termination of RNA synthesis, thereby preventing viral replication. This action reduces viral multiplication within host cells and helps limit disease progression. Remdesivir has demonstrated broad antiviral activity against several RNA viruses in preclinical and clinical studies.

Dosage and Administration

Bemsivir Injection is for intravenous use only and must be administered under the supervision of a qualified healthcare professional.

• The dosage and duration of therapy are determined by the treating physician based on the patient’s condition, body weight, renal function, and clinical response

• The injection is diluted prior to administration and infused intravenously over a specified period as per standard treatment guidelines

Patients should be closely monitored during therapy for renal and hepatic function.

Contraindications

Bemsivir Injection 5 mg/ml is contraindicated in patients with:

• Known hypersensitivity to Remdesivir or any component of the formulation

• Severe renal impairment, unless the potential benefit outweighs the risk

Side Effects

Commonly reported side effects may include:

• Nausea

• Headache

• Elevated liver enzymes

• Infusion-related reactions

Serious adverse effects such as hepatic dysfunction or renal impairment may occur and require close monitoring.

Precautions and Warnings

• Liver function tests should be performed before and during treatment

• Use with caution in patients with underlying liver or kidney disease

• Therapy should be discontinued if significant elevations in liver enzymes are observed

• Bemsivir Injection should only be used in settings where appropriate monitoring is available

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Pregnancy and Lactation

The use of Bemsivir Injection during pregnancy should be considered only if the potential benefit outweighs the potential risk to the fetus. It is not known whether Remdesivir is excreted in human milk; caution is advised when administered to breastfeeding mothers.

Storage Conditions

Store below 30°C as recommended. Protect from light. Keep out of the reach of children. Reconstituted or diluted solutions should be used according to hospital protocol.

Mode of Action

Remdesivir inhibits viral RNA-dependent RNA polymerase, blocking viral RNA synthesis and preventing replication of the virus within host cells.